Your browser doesn't support javascript.
loading
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.
Talaat, Kawsar R; Alaimo, Cristina; Martin, Patricia; Bourgeois, A Louis; Dreyer, Anita M; Kaminski, Robert W; Porter, Chad K; Chakraborty, Subhra; Clarkson, Kristen A; Brubaker, Jessica; Elwood, Daniel; Frölich, Rahel; DeNearing, Barbara; Weerts, Hailey; Feijoo, Brittany L; Halpern, Jane; Sack, David; Riddle, Mark S; Fonck, Veronica Gambillara.
Afiliación
  • Talaat KR; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: ktalaat@jhu.edu.
  • Alaimo C; LimmaTech Biologics AG, Schlieren, Switzerland.
  • Martin P; LimmaTech Biologics AG, Schlieren, Switzerland.
  • Bourgeois AL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Now at PATH Center for Vaccine Innovation and Access, Washington, DC, United States.
  • Dreyer AM; LimmaTech Biologics AG, Schlieren, Switzerland.
  • Kaminski RW; Walter Reed Army Institute of Research, Silver Spring, MD, United States.
  • Porter CK; Naval Medical Research Center, Silver Spring, MD, United States.
  • Chakraborty S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Clarkson KA; Walter Reed Army Institute of Research, Silver Spring, MD, United States.
  • Brubaker J; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Elwood D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Frölich R; LimmaTech Biologics AG, Schlieren, Switzerland.
  • DeNearing B; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Weerts H; Walter Reed Army Institute of Research, Silver Spring, MD, United States.
  • Feijoo BL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Halpern J; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Sack D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Riddle MS; Naval Medical Research Center, Silver Spring, MD, United States.
  • Fonck VG; LimmaTech Biologics AG, Schlieren, Switzerland.
EBioMedicine ; 66: 103310, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33862589
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Shigella / Vacunas contra la Shigella / Disentería Bacilar Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Shigella / Vacunas contra la Shigella / Disentería Bacilar Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article